Company intelligence / Profile preview

Zhejiang Xianju Cuize Pharmaceutical Technology

Taizhou, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

Zhejiang Xianju Cuize Pharmaceutical Technology is a clinical-stage biopharmaceutical company based in the Xianju Medical Device Town, China. The company focuses on the research and development of innovative small molecule drugs, particularly in the fields of reproductive health and endocrine disorders. Its lead programs include selective progesterone receptor modulators (SPRMs) and glucocorticoid receptor antagonists. Cuize Pharmaceutical aims to address unmet medical needs in women's health, such as endometriosis and uterine fibroids, through the development of high-quality, differentiated therapeutic candidates.

Therapeutic areas: EndocrinologyWomen's Health
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Zhejiang Xianju Cuize Pharmaceutical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhejiang Xianju Cuize Pharmaceutical Technology.

Explore the full profile